We are beat up now and FSYS has been struggling for a long time( i finally sold). We need to sit on our cash and only invest in sales and R&D till we have viable engines in the market.
I confess to having just put in a limit order for more shares.
Looks like a classic over-reaction to me.
This doggie may have rolled over, but it's far from dead.
We need a bit of positive PR to boost us back over a buck pretty quickly, though.
I'm 1/2 serious. The PPS whould have to rise so very much that a 500 to 1 split would be justified for me to come out whole on my ADXS investment.
We are real safe from that eventuality!
It could be argued, based on our past history, that a prudent thing to do is to sell 1/2 while the PPS is around $5.
When there isn't any positive news, we sink like a hot air balloon out of fuel.
I had a whole lot more shares, then they slid dramatically , and then we had a huge reverse split. And then the PPS proceeded to slide again.
ADXS has been characterized by these optimistic surges followed by long slides.
Another of my small biotech holdings had their much touted lead drug stumble badly in trials and lost 78% in one day.
The same could easily happen here. Most drug candidates fail to make it to FDA approval, but we have a pretty respectable pipeline and we only need 1 or 2 to succeed.
Another factor is that there are other checkpoint inhibitors coming down the pike to combine with our platform. None of that will happen fast.
Roughly 1 in 10 ph 3 trials yield a marketable drug, was the old rule of thumb.
A great many very promising drug candidates never make it across the finish line.
The cost of advancing a drug through the trials and the FDA is enormous.
I'd love to see it happen, but don't count your proverbial chickens quite yet.
Just sit tight. They have 3 drugs in ph3 trials and a huge pipeline.
As unprofitable biotech's go, this one seems like a good bet.